MHLW Counterfeit Drug Panel Agrees on “Voluntary” Introduction of GDP in Japan

MHLW Panel on Counterfeit Drugs on Nov. 10 A health ministry panel on counterfeit drugs on November 10 agreed to introduce Good Distribution Practice (GDP) guidelines in Japan on a voluntary basis, calling on all parties involved in ethical drug...read more